PHARMACYTE BIOTECH, INC. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
PHARMACYTE BIOTECH, INC. (PMCB) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $1.54 thousand for the 12-month period ending 2017-04-30, per its 10-K filed 2017-07-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-07-27
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-04-30 was $483.00, a 32.33% increase year-over-year.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-01-31 was $131.00.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-10-31 was $356.00, a 83.51% increase year-over-year.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-07-31 was $569.00, a 9.97% decline year-over-year.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2017 was $1.54K, a 29.22% increase from fiscal 2016.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $1.19K, a 97.36% decline from fiscal 2015.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $45.14K, a 996.45% increase from fiscal 2014.
- PHARMACYTE BIOTECH, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $4.12K.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|
| 2017-04-30 | $483.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $614.00 derived: sum of 2 quarters · filed 2017-07-27 | $970.00 derived: sum of 3 quarters · filed 2017-07-27 | $1.54K 10-K · filed 2017-07-27 |
| 2017-01-31 | $131.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | $487.00 derived: sum of 2 quarters · filed 2017-03-13 | $1.06K 10-Q · filed 2017-03-13 | $1.42K derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-10-31 | $356.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | $925.00 10-Q · filed 2016-12-02 | $1.29K derived: sum of 3 quarters · filed 2017-07-27 | $1.29K derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-07-31 | $569.00 10-Q · filed 2016-09-06 | $934.00 derived: sum of 2 quarters · filed 2017-07-27 | $934.00 derived: sum of 3 quarters · filed 2017-07-27 | $1.13K derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-04-30 | $365.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $365.00 derived: sum of 2 quarters · filed 2017-07-27 | $559.00 derived: sum of 3 quarters · filed 2017-07-27 | $1.19K 10-K · filed 2017-07-27 |
| 2016-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | $194.00 derived: sum of 2 quarters · filed 2017-03-13 | $826.00 10-Q · filed 2017-03-13 | $44.45K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-10-31 | $194.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | $826.00 10-Q · filed 2016-12-02 | $44.45K derived: sum of 3 quarters · filed 2016-12-02 | $45.97K derived: sum of 4 quarters · filed 2016-12-02 |
| 2015-07-31 | $632.00 10-Q · filed 2016-09-06 | $44.26K derived: sum of 2 quarters · filed 2016-09-06 | $45.77K derived: sum of 3 quarters · filed 2016-09-06 | $45.77K derived: sum of 4 quarters · filed 2016-09-06 |
| 2015-04-30 | $43.62K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $45.14K derived: sum of 2 quarters · filed 2016-07-29 | $45.14K derived: sum of 3 quarters · filed 2016-07-29 | $45.14K 10-K · filed 2016-07-29 |
| 2015-01-31 | $1.52K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-03-08 | $1.52K derived: sum of 2 quarters · filed 2016-03-08 | $1.52K 10-Q · filed 2016-03-08 | $5.63K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-10-31 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $0.00 10-Q/A · filed 2016-01-19 | $4.12K derived: sum of 3 quarters · filed 2016-07-29 | $4.12K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-07-31 | $0.00 10-Q/A · filed 2016-01-19 | $4.12K derived: sum of 2 quarters · filed 2016-07-29 | $4.12K derived: sum of 3 quarters · filed 2016-07-29 | $4.12K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-04-30 | $4.12K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $4.12K derived: sum of 2 quarters · filed 2016-07-29 | $4.12K derived: sum of 3 quarters · filed 2016-07-29 | $4.12K 10-K · filed 2016-07-29 |
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $0.00 10-Q · filed 2015-03-13 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-07-31 | $0.00 10-Q · filed 2014-09-15 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 10-K/A · filed 2016-01-19 |
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 | $0.00 derived: sum of 3 quarters · filed 2013-12-16 | $0.00 derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | $0.00 10-Q · filed 2013-09-16 | $0.00 derived: sum of 2 quarters · filed 2013-09-16 | $0.00 derived: sum of 3 quarters · filed 2013-09-16 | $0.00 derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $0.00 derived: sum of 2 quarters · filed 2013-07-29 | $0.00 derived: sum of 3 quarters · filed 2013-07-29 | $0.00 10-K · filed 2013-07-29 |
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2013-03-26 | $0.00 10-Q · filed 2013-03-26 | |
| 2011-10-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-12-26 | $0.00 10-Q · filed 2012-12-26 | ||
| 2011-07-31 | $0.00 10-Q/A · filed 2011-09-20 | |||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | $0.00 derived: sum of 2 quarters · filed 2012-03-21 | $0.00 10-Q · filed 2012-03-21 | |
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | $0.00 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |